HOME Top Market Reports Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

Liquid Biopsy Market by Cancer Type (Lung, Breast, Colorectal, Prostate), Circulating Biomarkers (Circulating Tumor Cells, Circulating Tumor DNA, Cell-Free DNA), Product (Instruments, Assay Kits), End User (Reference Laboratory) - Global Forecast to 2022

By: marketsandmarkets.com
Publishing Date: September 2017
Report Code: MD 4456

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global liquid biopsy market is projected to be valued at USD 580.0 Million in 2016 and is expected to grow at a CAGR of 23.4% to reach to USD 2,047.9 Million by 2022. Base year considered for the report is 2016 and forecast period includes 2017–2022. Some of the key factors driving the growth of this market include increasing prevalence of cancer, increasing preference for noninvasive procedures, and availability of funding for liquid biopsy R&D.

Objectives of the Study

  • To define, describe, and forecast the liquid biopsy market on the basis of product, clinical application, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and industry-specific challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions (along with countries), namely, North America, Europe, Asia Pacific, and the Rest of the World
  • To profile key players and comprehensively analyze their market shares and core competencies
  • To track and analyze competitive developments such as acquisitions, product developments, partnerships, agreements, expansions, and collaborations in the liquid biopsy market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global liquid biopsy market and estimate the size of other dependent submarkets. Various secondary sources such as associations (including Food and Drug Administration (FDA), American Society of Anesthesiologists (ASA), and Centers for Disease Control and Prevention (CDC)), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Liquid Biopsy Market

To know about the assumptions considered for the study, download the pdf brochure

The major players in the global liquid biopsy market are QIAGEN N.V. (Netherlands), Roche Diagnostics (US), Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDxHealth SA (US).

Target Audience:

  • Liquid biopsy system manufacturers, suppliers, and distributors
  • Research institutes
  • Physicians and surgeons
  • Healthcare service providers and clinical research organizations
  • Market research and consulting firms

Scope of the Report:

The research report categorizes the liquid biopsy market into the following segments and subsegments:

Liquid biopsy Market, by Product

  • Assays Kits
  • Instruments
  • Services

Liquid biopsy Market, by Circulating Biomarker

  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (ctDNA)
  • Cell-Free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Other Circulating Biomarkers*

*Other circulating biomarkers include circulating RNA (ctRNA and cfRNA) and cell-free protein biomarkers.

Liquid biopsy Market, by Clinical Application

  • Early Cancer Screening
  • Therapy Selection
  • Treatment Monitoring
  • Recurrence Monitoring Orthopedics

Liquid biopsy Market, by Application

  • Oncology
    • Lung Cancer
    • Breast Cancer 
    • Colorectal Cancer
    • Prostate Cancer
    • Liver Cancer
    • Other Cancers (bladder cancer, pancreatic cancer, brain and nervous system cancer, ovarian cancer and melanoma)
  • Non-Cancer Application

Liquid biopsy Market, by End User

  • Reference Laboratories 
  • Hospitals and Physician Laboratories
  • Academic and Research Centers
  • Other End Users

Liquid biopsy Market, by Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • RoW

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)

Table of Contents

1 Introduction (Page No. - 16)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 19)
    2.1 Research Approach
           2.1.1 Secondary Data
                    2.1.1.1 Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation
    2.3 Market Breakdown and Data Triangulation
    2.4 Assumptions for the Study

3 Executive Summary (Page No. - 27)

4 Premium Insights (Page No. - 31)
    4.1 Liquid Biopsy: Market Overview
    4.2 Liquid Biopsy Market, By Clinical Application (2017)
    4.3 Liquid Biopsy Market: Geographic Growth Opportunities
    4.4 Liquid Biopsy Market: Geographic Mix
    4.5 Liquid Biopsy Market: Established vs Emerging Markets

5 Market Overview (Page No. - 35)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 Increasing Prevalence of Cancer
                    5.2.1.2 Increasing Preference for Noninvasive Procedures
                    5.2.1.3 Initiatives Undertaken By Government and Global Health Organizations
                    5.2.1.4 Technological Advancement to Augment Market Revenues
                    5.2.1.5 Rising Emphasis on Personalized Medicine
                    5.2.1.6 Availability of Funding for Liquid Biopsy R&D
           5.2.2 Restraints
                    5.2.2.1 Low Sensitivity and Specificity
           5.2.3 Opportunities
                    5.2.3.1 Growing Interest in Liquid Biopsy
           5.2.4 Challenges
                    5.2.4.1 Unclear Regulatory and Reimbursement Scenario

6 Liquid Biopsy Market, By Product and Service (Page No. - 46)
    6.1 Introduction
    6.2 Assay Kits
    6.3 Instruments
    6.4 Services

7 Liquid Biopsy Market, By Circulating Biomarker (Page No. - 52)
    7.1 Introduction
    7.2 Circulating Tumor Cells
    7.3 Circulating Tumor DNA (CTDNA)
    7.4 Cell-Free DNA
    7.5 Extracellular Vesicles (Evs)
    7.6 Other Circulating Biomarkers

8 Liquid Biopsy Market, By Clinical Application (Page No. - 61)
    8.1 Introduction
    8.2 Early Cancer Screening
    8.3 Therapy Selection
    8.4 Treatment Monitoring
    8.5 Recurrence Monitoring

9 Liquid Biopsy Market, By Application (Page No. - 67)
    9.1 Introduction
    9.2 Cancer Applications
           9.2.1 Lung Cancer
           9.2.2 Breast Cancer
           9.2.3 Colorectal Cancer
           9.2.4 Prostate Cancer
           9.2.5 Liver Cancer
           9.2.6 Other Cancers
    9.3 Non-Cancer Applications

10 Liquid Biopsy Market, By End User (Page No. - 80)
     10.1 Introduction
     10.2 Reference Laboratories
     10.3 Hospitals and Physician Laboratories
     10.4 Academic and Research Centers
     10.5 Other End Users

11 Liquid Biopsy Market, By Region (Page No. - 86)
     11.1 Introduction
     11.2 North America
             11.2.1 US
             11.2.2 Canada
     11.3 Europe
             11.3.1 Germany
             11.3.2 France
             11.3.3 UK
             11.3.4 Rest of Europe
     11.4 Asia Pacific
             11.4.1 Japan
             11.4.2 China
             11.4.3 India
             11.4.4 Rest of Asia Pacific
     11.5 Rest of the World (RoW)

12 Competitive Landscape (Page No. - 146)
     12.1 Market Ranking Analysis

13 Company Profiles (Page No. - 147)
(Overview, Products Offered, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments.)*
     13.1 Biocept, Inc.
     13.2 Qiagen N.V.
     13.3 Roche Diagnostics
     13.4 Bio-Rad Laboratories, Inc.
     13.5 Myriad Genetics, Inc
     13.6 Menarini-Silicon Biosystems
     13.7 Trovagene, Inc.
     13.8 Guardant Health, Inc.
     13.9 Mdxhealth SA
     13.10 Genomic Health, Inc.
     13.11 Raindance Technologies, Inc
     13.12 Thermo Fisher Scientific Inc.
     13.13 Illumina, Inc.

*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. - 195)
     14.1 Insights of Industry Experts
     14.2 Discussion Guide
     14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     14.4 Introducing RT: Real-Time Market Intelligence
     14.5 Available Customizations
     14.6 Related Reports
     14.7 Author Details


List of Tables (133 Tables)

Table 1 Conferences and Awareness Programs on Liquid Biopsy
Table 2 Liquid Biopsy Products Launched in Recent Years
Table 3 Liquid Biopsy Market: Funding (2014 - 2017)
Table 4 Companies Selling/Developing Liquid Biopsy Tests for Oncology, in the US
Table 5 Liquid Biopsy Market, By Product and Service, 2015–2022 (USD Million)
Table 6 Liquid Biopsy Market for Assay Kits, By Country, 2015–2022 (USD Million)
Table 7 Specifications: Ngs and Ddpcr for Cancer Liquid Biopsies
Table 8 Liquid Biopsy Market for Instruments, By Country, 2015–2022 (USD Million)
Table 9 Liquid Biopsy Market for Services, By Country, 2015–2022 (USD Million)
Table 10 Advantages and Limitations of CTCS, CTDNA, and Exosomes
Table 11 Liquid Biopsy Market, By Circulating Biomarker, 2015–2022 (USD Million)
Table 12 Companies Active in the CTCS Segment
Table 13 Liquid Biopsy Market for Circulating Tumor Cells, By Country, 2015–2022 (USD Million)
Table 14 Liquid Biopsy Market for Circulating Tumor DNA, By Country, 2015–2022 (USD Million)
Table 15 Liquid Biopsy Market for Cell-Free DNA, By Country, 2015–2022 (USD Million)
Table 16 Liquid Biopsy Market for Extracellular Vesicles, By Country, 2015–2022 (USD Million)
Table 17 Liquid Biopsy Market for Other Circulating Biomarkers, By Country, 2015–2022 (USD Million)
Table 18 Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 19 Liquid Biopsy Market for Early Cancer Screening, By Country/Region, 2015–2022 (USD Thousands)
Table 20 Liquid Biopsy Market for Therapy Selection, By Country/Region, 2015–2022 (USD Million)
Table 21 Liquid Biopsy Market for Treatment Monitoring, By Country/Region, 2015–2022 (USD Million)
Table 22 Liquid Biopsy Market for Recurrence Monitoring, By Country/Region, 2015–2022 (USD Million)
Table 23 Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 24 Liquid Biopsy Market for Cancer Applications, By Country/Region, 2015–2022 (USD Million)
Table 25 Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 26 Liquid Biopsy Market for Lung Cancer, By Country/Region, 2015–2022 (USD Million)
Table 27 Liquid Biopsy Market for Breast Cancer, By Country/Region, 2015–2022 (USD Million)
Table 28 Liquid Biopsy Market for Colorectal Cancer, By Country/Region, 2015–2022 (USD Million)
Table 29 Liquid Biopsy Market for Prostate Cancer, By Country/Region, 2015–2022 (USD Million)
Table 30 Liquid Biopsy Market for Liver Cancer, By Country/Region, 2015–2022 (USD Million)
Table 31 Liquid Biopsy Market for Other Cancers, By Country/Region, 2015–2022 (USD Million)
Table 32 Liquid Biopsy Market for Non-Cancer Applications, By Country/Region, 2015–2022 (USD Million)
Table 33 Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 34 Liquid Biopsy Market for Reference Laboratories, By Country/Region, 2015–2022 (USD Million)
Table 35 Liquid Biopsy Market for Hospitals and Physician Laboratories, By Country/ Region, 2015–2022 (USD Million)
Table 36 Liquid Biopsy Market for Academic and Research Centers, By Country/ Region, 2015–2022 (USD Million)
Table 37 Liquid Biopsy Market for Other End Users, By Country/Region, 2015–2022 (USD Million)
Table 38 Liquid Biopsy Market, By Region, 2015–2022 (USD Million)
Table 39 Estimated New Cases of Cancer in 2017, US
Table 40 North America: Liquid Biopsy Market, By Country, 2015–2022 (USD Million)
Table 41 North America: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 42 North America: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 43 North America: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 44 North America: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 45 North America: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 46 North America: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 47 US: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 48 US: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 49 US: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 50 US: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 51 US: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 52 US: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 53 Overview of the Breast, Cervical, and Colorectal Cancer Screening Programs Across Canada
Table 54 Canada: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 55 Canada: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 56 Canada: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 57 Canada: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 58 Canada: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 59 Canada: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 60 Europe: Liquid Biopsy Market, By Country, 2015–2022 (USD Million)
Table 61 Europe: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 62 Europe: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 63 Europe: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 64 Europe: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 65 Europe: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 66 Europe: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 67 Germany: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 68 Germany: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 69 Germany: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 70 Germany: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 71 Germany: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 72 Germany: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 73 France: Key Market Indicators
Table 74 France: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 75 France: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 76 France: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 77 France: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 78 France: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 79 France: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 80 UK: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 81 UK: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 82 UK: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 83 UK: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 84 UK: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 85 UK: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 86 RoE: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 87 RoE: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 88 RoE: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 89 RoE: Liquid Biopsy Market for Cancer Applications, By Cancer Type, 2015–2022 (USD Million)
Table 90 RoE: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 91 RoE: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 92 Asia Pacific: Liquid Biopsy Market, By Country, 2015–2022 (USD Million)
Table 93 Asia Pacific: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 94 Asia Pacific: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 95 Asia Pacific: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 96 Asia Pacific: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 97 Asia Pacific: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 98 Asia Pacific: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 99 Japan: Key Market Indicators
Table 100 Japan: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 101 Japan: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 102 Japan: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 103 Japan: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 104 Japan: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 105 Japan: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 106 China: Key Market Indicators
Table 107 China: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 108 China: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 109 China: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 110 China: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 111 China: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 112 China: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 113 India: Key Market Indicators:
Table 114 India: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 115 India: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 116 India: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 117 India: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 118 India: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 119 India: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 120 RoAPAC: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 121 RoAPAC: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 122 RoAPAC: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 123 RoAPAC: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 124 RoAPAC: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 125 RoAPAC: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 126 RoW: Liquid Biopsy Market, By Product & Service, 2015–2022 (USD Million)
Table 127 RoW: Liquid Biopsy Circulating Biomarkers Market, By Type, 2015–2022 (USD Million)
Table 128 RoW: Liquid Biopsy Market, By Application, 2015–2022 (USD Million)
Table 129 RoW: Liquid Biopsy Market, By Type of Cancer, 2015–2022 (USD Million)
Table 130 RoW: Liquid Biopsy Market, By Clinical Application, 2015–2022 (USD Million)
Table 131 RoW: Liquid Biopsy Market, By End User, 2015–2022 (USD Million)
Table 132 Liquid Biopsy Market, By Key Player, 2016
Table 133 Chf to USD Conversion Rates (2014-2016)


List of Figures (44 Figures)

Figure 1 Liquid Biopsy: Market Segmentation
Figure 2 Research Design
Figure 3 Market Size Estimation: Bottom-Up Approach
Figure 4 Market Size Estimation: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Liquid Biopsy Market, By Product and Service, 2017 vs 2022
Figure 7 Liquid Biopsy Market, By Clinical Application, 2017 vs 2022
Figure 8 Liquid Biopsy Market, By Application, 2017 vs 2022
Figure 9 Liquid Biopsy Market, By End User, 2017 vs 2022
Figure 10 Geographical Snapshot of the Global Liquid Biopsy Market
Figure 11 Increasing Cancer Prevalence—Major Growth Driver for the Liquid Biopsy Market
Figure 12 Therapy Selection Segment to Dominate the Liquid Biopsy Market in 2017
Figure 13 North America to Account for the Largest Share of the Liquid Biopsy Market in 2017
Figure 14 Asia Pacific to Grow at the Highest CAGR During the Forecast Period
Figure 15 Emerging Markets to Grow at Higher CAGRs From 2017 to 2022
Figure 16 Liquid Biopsy Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 Estimated New Cancer Cases and Estimated Deaths in US (2017)
Figure 18 Cancer Prevalence and Mortality Rate, By Country (2012)
Figure 19 Pubmed Publications—Liquid Biopsy
Figure 20 Estimated New Cancer Cases and Deaths (2016)
Figure 21 North America: Liquid Biopsy Market Snapshot
Figure 22 US: Cancer Statistics
Figure 23 Canada: Cancer Statistics
Figure 24 Europe: Proportion of Deaths Due to Cancer in the Eu (2013)
Figure 25 Europe: Deaths Due to Cancer in the Population Aged 65 and Over (2013)
Figure 26 Germany: Cancer Incidence and Prevalence, 2010 vs 2015
Figure 27 UK: Estimated Number of People Living With Cancer
Figure 28 RoE: Incidence and Prevalence of Cancer, 2015
Figure 29 Asia Pacific: Liquid Biopsy Market Snapshot
Figure 30 Japan: Cancer Incidence and Prevalence Number, 2010 vs 2015
Figure 31 China: Cancer Incidence and Prevalence Number, 2010 vs 2015
Figure 32 India: Cancer Incidence and Prevalence Number, 2010 vs 2015
Figure 33 Rest of Asia Pacific: Number of Cancer Cases, 2015
Figure 34 Biocept, Inc.: Company Snapshot (2016)
Figure 35 Qiagen N.V.: Company Snapshot (2016)
Figure 36 Roche Diagnostics: Company Snapshot (2016)
Figure 37 Bio-Rad Laboratories, Inc.: Company Snapshot (2016)
Figure 38 Myriad Genetics, Inc: Company Snapshot (2016)
Figure 39 Menarini Group: Company Snapshot (2016)
Figure 40 Trovagene Inc.: Company Snapshot (2016)
Figure 41 Mdxhealth: Company Snapshot (2016)
Figure 42 Genomic Health, Inc.: Company Snapshot (2016)
Figure 43 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 44 Illumina Inc.: Company Snapshot (2016)

The global liquid biopsy market is projected to reach USD 2,047.9 Million by 2022 from USD 715.7 Million in 2017, at a CAGR of 23.4%. Factors such as increasing prevalence of cancer, increasing preference for noninvasive procedures, initiatives undertaken by government and global health organizations, technological advancements to augment market revenues, rising emphasis on personalized medicine in clinical practice, and increased funding for liquid biopsy R&D are driving the growth of the liquid biopsy market.

The number of companies offering liquid biopsy devices is increasing, globally. Major market players are focusing on strengthening their product offerings, mergers and acquisitions, and geographic presence by entering into contracts and agreements with other established players in the market. For instance, in January 2017, Bio-Rad Laboratories, Inc. (US) entered into a definitive agreement with RainDance Technologies, Inc. (US) to acquire the latter. The acquisition will result in Bio-Rad's expansion into next-generation sequencing applications.

The report analyzes the liquid biopsy market by product, circulating biomarker, clinical application, application, end user, and region. On the basis of product and service, the liquid biopsy market is segmented into assay kits, instruments, and services. The assay kits segment is expected to account for the largest share of the liquid biopsy market in 2017. Factors such as the increasing demand for liquid biopsy tests, increasing applications of liquid biopsies, and the need for reliable and specific assays are expected to drive the liquid biopsy market in the coming years.

On the basis of clinical application, the liquid biopsy market is segmented into early cancer screening, therapy selection, treatment monitoring, and recurrence monitoring. The therapy selection segment is expected to account for the largest share of the liquid biopsy market in 2017. This is due to the potential benefits of liquid biopsy in therapy selection.

On the basis of application, the liquid biopsy market is segmented into cancer and non-cancer applications. The cancer application segment is expected to account for the largest share of the liquid biopsy market in 2017. Based on end user, the liquid biopsy market is segmented into reference laboratories, hospitals and physician laboratories, academic and research centers, and other end users (public health laboratories, pathology laboratories, and small molecular laboratories). In 2017, the reference laboratories segment is expected to account for the largest share of the liquid biopsy market. The large share of this segment is attributed to the increased volume of liquid biopsy test samples outsourced to reference laboratories.

Liquid Biopsy Market

Geographically, the global liquid biopsy market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2022, North America is expected to dominate the market which can be attributed to the easy accessibility and high adoption of advanced diagnostic technologies (such as PCR and NGS) among healthcare professionals. The APAC region is expected to register the highest CAGR during the forecast period. Growth in this market can be attributed to a number of factors such as rising disposable incomes in the middle-class populations infrastructural developments, rising penetration of cutting-edge diagnostic technologies, the growing focus of global life science companies in this region, government initiatives to increase awareness about genome-based diagnostic procedures, and the increasing incidence rate of cancer.

In 2016, QIAGEN N.V. (Netherlands), Roche Diagnostics (US), and Illumina, Inc. (US) dominated the global liquid biopsy market. Some of the other players competing in this market are Bio-Rad Laboratories Inc. (US), Myriad Genetics, Inc. (US), Menarini Silicon Biosystems (Italy), Genomic Health, Inc. (US), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Biocept, Inc. (US), Trovagene, Inc. (US), Guardant Health, Inc. (US), RainDance Technologies, Inc. (US), and MDxHealth SA (US).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Medical Devices Markets on KnowledgeStore
Request Demo